The Tissue Systems Pathology Test Predicts Risk of Progression in Patients With Barrett’s Esophagus

Effect estimates of TSP-9 performance demonstrate that the test provides risk stratification for BE patients. The TSP-9 test can provide clinically impactful results to enable escalation of care for high-risk patients or to identify low-risk patients who can be safely managed with routine surveillance.